| Swarna Gaddam, MD | |
|
1100 Central Ave Se, Albuquerque, NM 87106-4930 | |
| (505) 724-6125 | |
| Not Available |
| Full Name | Swarna Gaddam |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 1100 Central Ave Se, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750658639 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
With the decline in cigarette smoking, students have taken to other ‘safer' forms of smoking, especially hookah smoking. However, a pioneering study shows that a single puff from a hookah exposes the smoker to as high a level of certain toxins as an entire cigarette does!
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 4 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
With the decline in cigarette smoking, students have taken to other ‘safer' forms of smoking, especially hookah smoking. However, a pioneering study shows that a single puff from a hookah exposes the smoker to as high a level of certain toxins as an entire cigarette does!
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swarna Gaddam, MD Po Box 26666, Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-6770 | Swarna Gaddam, MD 1100 Central Ave Se, Albuquerque, NM 87106-4930 Ph: (505) 724-6125 |
News Archive
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
With the decline in cigarette smoking, students have taken to other ‘safer' forms of smoking, especially hookah smoking. However, a pioneering study shows that a single puff from a hookah exposes the smoker to as high a level of certain toxins as an entire cigarette does!
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
Despite maturity in some segments, the European patient monitoring market still offers pockets of high growth potential. Unique strategies and technologically innovative products will sustain further expansion, even as the enthusiasm of patients and doctors for more sophisticated offerings will counteract challenges faced by the market.
› Verified 4 days ago
Dr. Alberto Aguayo Rico, M.D, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 San Mateo Blvd Se, Albuquerque, NM 87108 Phone: 505-462-7333 Fax: 505-462-7440 | |
Peter Guido, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Jefferson St Ne, Ste 800, Albuquerque, NM 87109 Phone: 505-872-6000 Fax: 505-872-6003 | |
Kenneth A Bell, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Transport St Se, Albuquerque, NM 87106 Phone: 505-262-7110 Fax: 505-262-7308 | |
Joseph F. Oser, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
Dr. Stanley Zissman Berman, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7416 Vista Del Arroyo Ave Ne, Albuquerque, NM 87109 Phone: 505-884-7270 | |
Huyentrang Vu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Tamara Goodman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 |